BlackRock Fund Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $57.5M | Buy |
1,173,660
+137,064
| +13% | +$6.71M | 0.01% | 1590 |
|
|
2016
Q3 | $49.6M | Buy |
1,036,596
+93,300
| +10% | +$4.46M | 0.01% | 1585 |
|
|
2016
Q2 | $50.6M | Buy |
943,296
+12,490
| +1% | +$670K | 0.01% | 1483 |
|
|
2016
Q1 | $41.6M | Sell |
930,806
-21,925
| -2% | -$980K | 0.01% | 1564 |
|
|
2015
Q4 | $36.4M | Buy |
952,731
+43,737
| +5% | +$1.67M | 0.01% | 1694 |
|
|
2015
Q3 | $28.9M | Buy |
908,994
+33,386
| +4% | +$1.06M | 0.01% | 1770 |
|
|
2015
Q2 | $28.9M | Sell |
875,608
-16,988
| -2% | -$561K | 0.01% | 1887 |
|
|
2015
Q1 | $36.7M | Buy |
892,596
+60,739
| +7% | +$2.5M | 0.01% | 1715 |
|
|
2014
Q4 | $33.9M | Buy |
831,857
+74,972
| +10% | +$3.05M | 0.01% | 1738 |
|
|
2014
Q3 | $27.7M | Buy |
756,885
+65,271
| +9% | +$2.39M | 0.01% | 1757 |
|
|
2014
Q2 | $32M | Buy |
691,614
+22,987
| +3% | +$1.06M | 0.01% | 1706 |
|
|
2014
Q1 | $27.5M | Buy |
668,627
+7,990
| +1% | +$328K | 0.01% | 1824 |
|
|
2013
Q4 | $25.2M | Buy |
660,637
+319,875
| +94% | +$12.2M | 0.01% | 1845 |
|
|
2013
Q3 | $8.14M | Buy |
340,762
+37,605
| +12% | +$898K | ﹤0.01% | 2501 |
|
|
2013
Q2 | $5.15M | Buy |
+303,157
| New | +$5.15M | ﹤0.01% | 2665 |
|